« Merck & Co. | Main | Amgen »

Dec12
AstraZeneca

Swiss pharmaceutical AstraZeneca (NYSE:AZN) was 8th on the list of R&D research spending with a 2006 expenditure of $2.95 bn EUR and 7th for overall sales in 2006. AstraZeneca saw its Seroquel XR for schizophrenia get FDA approval this year and received U.S. Food and Drug Administration approval to sell its cholesterol drug, Crestor, to also treat clogged arteries. Last week the FDA issued final assessment of studies on Nexium and found there was no likely cardiac risk associated with long term use of the drug.  The company has 31 Phase III drugs , 19 in Phase II and 39 in Phase I.

Pending Approval

Nexium - NSAID GI side effects – symptom resolution/ulcer healing
Seroquel - Bipolar maintenance
FluMist - Influenza virus
Symbicort - COPD

Phase III

AZD6140 - Arterial thrombosis 
Saxagliptin - Diabetes 
Dapagliflozin - Diabetes
Zactima - NSCLC
Recentin - NSCLC and CRC/Recurrent glioblastoma 
ZD4054 - Hormone resistant prostate cancer
Motavizumab - RSV prevention
Atacand - diabetic retinopathy
Atacand Plus - 32/12.5 mg, 32/25 mg for hypertension
Crestor - Outcomes CHF
Crestor - Outcomes End Stage Renal Disease
Nexium - Peptic ulcer bleeding
Nexium low dose aspirin combination - Low dose aspirin
associated peptic ulcer
Seroquel XR - Generalised anxiety disorder
Seroquel XR - Major depressive disorder
Seroquel XR - Bipolar mania
Seroquel XR - Bipolar depression
Faslodex - 1st line advanced breast cancer
Faslodex - Adjuvant

[Source: FierceBiotech]


1 Comments/Trackbacks




» 2007 Edition of the European Commission's Report of R&D Spending from PharmaGazette
The 2007 edition of the European Commission's annual report of research and development spending places Pfizer Inc. at the top of the heap outspending all other industries.Pharmaceuticals and biotechnology became the top R&D spenders beating ou... [Read More]

submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Merck & Co. | Main | Amgen »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb